Age was predicted by the mean amplitude of fast spindles (GLMM, F 1,8 = 27.608, P = 0.001), which decreased with years of age; was predicted by a decrease in their density (GLMM, F 1,8 = 6.454, P = 0.035), while frequency showed a trend to increase with age (GLMM, F 1,8 = 4.132, P = 0.077).
The high IL-10 group also showed a trend of inferior PFS compared with the low IL-10 group in AITL (Figure 3B , P = 0.077).
High MYO18B methylation showed a trend towards better response (PFS: HR = 0.67 (0.43–1.04), P = 0.077) but no association with overall survival (Additional file 3 : Figure S5A, B).
Elderly patients showed a trend towards increased LOS (17.3 vs. 14.1 days; p = 0.077) and nosocomial infection rates (30% vs. 24%; p = 0.15), though these did not reach statistical significance.
Only the variable “being married” showed a trend to be significant (Z = −1.767, p = 0.077) ( Tables 4 and 5 ).
These patients showed a trend to be older (67.8 vs. 59.7 years, p = 0.077); however, no significant difference was found in the primary tumor distribution ( p = 0.239) or tumor volume ( p = 0.331).
Moreover, LF% during the AW stage showed a trend of a positive correlation with cognitive performance for all mice at the early stage (r = 0.441, p = 0.077) and APP/PS1 at the early stage alone (r = 0.566, p = 0.070).
During the fifth wave (T3) peace of mind showed a trend to significant decrease compared to before the pandemic (T0) and during the first wave (T1) ( p = 0.077 and p = 0.068 respectively).
Moderate Effects of nor-NOHA in Balb/cJ Mice Infected with Mtb Balb/cJ mice infected with Mtb (200 CFU, i.n.) and treated with nor-NOHA (0.04 mg/g i.p.) daily for 8 weeks ( Figure 3 A) showed a trend ( p = 0.077) towards a decrease in bacterial burden in the lungs ( Figure 3 B).
Similarly, patients treated with HMAs plus ruxolitinib showed a trend towards longer survival than HMAs alone [one-year OS rate: 25% (95%CI: 16–36%; I 2 =68.2%) and 11% (95% CI: 3–24%; I 2 =31.8%) respectively, p = .0774; two-year OS rate: 33% (95% CI: 15–54%; I 2 =34.8%) and 3% (95% CI: 0–18%; I 2 =65.2%), p = .051; Figure 4(c,d) ].
Specifically, the brain content of mRNAs encoding KC decreased significantly after COAM treatment (decrease of median by 4.7 fold, P <0.05) and MIP-2 mRNA showed a trend towards decrease ( P = 0.0774).
High KRAS mut cfDNA levels (>25 copies/mL) before the start of systemic chemotherapy were inversely associated with PFS (HR = 2.07, 95% CI: 1.011–4.229, p = 0.0057; Supplemental Figure S2A ) and also showed a trend toward inferior OS (HR = 1.72, 95% CI: 0.850–3.489, p = 0.0775; Supplemental Figure S2B ).
Currently, only a PBPK study has demonstrated that CL of pyrazinamide correlated with creatinine clearance ( p = 0.0349) and showed a trend toward smaller CL values with advancing age ( p = 0.0778) ( Peloquin et al., 1997 ).
In both cohorts of survival from diagnosis and from symptom onset, the comparison showed a trend favoring biopsy + PET + MRI + EMG-NCS over biopsy + PET + MRI + ultrasound ( p = 0.0779 and p = 0.0962, respectively).
Number of eggs per goose in the GDL light group showed a trend toward higher values than P7H light group (81.82 vs 55.45 egg/bird; p = 0.0779).
Although not statistically significant, female patients showed a trend toward longer hospitalization (β = 12.14 days, p = 0.078), which may warrant further investigation.
Sarcomatoid differentiation showed a trend toward worse survival (HR 1.69, 95% CI: 0.93–3.07; p = 0.078).
The LR model predicted that paclitaxel-sensitive patients showed a trend for longer PFS (median PFS 6.48 vs. 2.33 months, P = 0.078) and OS (median OS 12.20 vs. 8.61 months, P = 0.099).
FOS treatment showed a trend ( p = 0.078) toward lower alpha diversity relative to CON ( Figure 3 A).
Finally, the presence of concomitant DE lesions infiltrating the vagina/rectovaginal space (#Enzian compartment A) and/or sacrouterine ligaments/parametrium (#Enzian compartment B) did not alter the severity of preoperative dyschezia ( p = 0.493) or dysmenorrhea ( p = 0.128) but showed a trend toward affecting gastrointestinal function ( p = 0.078) and was significantly associated with dyspareunia ( p = 0.035).
In addition, repeated measures ANOVA showed a trend toward a time-dependent interaction of eGFR between the 2 groups during the first 4 to 48 wk of treatment ( P = 0.078).
However, the follow-up analysis of RGS16 mRNA levels 30min after exercise compared to baseline resulted in no significant difference in the control trial ( p =0.445) but showed a trend toward reduced levels in the supplementation trial ( p =0.078).
The examination of serum obtained from the NAC broilers showed a trend for increased activity of GSH-Px ( P = 0.078) and a significant decrease ( P < 0.05) in plasma MDA levels when compared to the HS group (Fig. 6 a and b).
Drug overdose or chemical ingestion showed a trend of first attempters (n = 93, 66.9%) to use them more than multiple attempters (n = 61, 56.0%) (χ 2 = 3.11, P = 0.078).
Regarding BCR-ABL status, our data showed a trend toward higher positivity in the low miR-493-3p expression group (13/55, 23.6% vs. 5/48, 10.4%; P = 0.078), approaching but not reaching statistical significance.